# Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer

> **NCT01326468** · NA · WITHDRAWN · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University**

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** Temsirolimus
- **DRUG:** Cetuximab
- **DRUG:** Cisplatin
- **DEVICE:** Radiation Therapy

## Key facts

- **NCT ID:** NCT01326468
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-12-08
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** funding
- **Last updated:** 2025-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01326468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01326468, "Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01326468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*